Protein identified as potential drug target for pancreatic cancer
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, according to a study by the Institute for Applied Cancer Science.Science Daily
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Endocrinology | Pancreas | Pancreatic Cancer | Science | Study